HNN 3.0

📨 Welcome to our December Newsletter! As we wrap up 2024, this final issue of the HNN Health Newsletter this year. This month, we’re putting the spotlight on Calls, providing essential updates and information. The HNN 3.0 Team wishes you a joyful holiday season and a fantastic start to the New Year! Read NL: https://lnkd.in/ep7-G_hE

🔴 #GlobalGlobal Health EDCTP3: Work Programme 2025 is out! 👉 https://lnkd.in/ebQKVQTc

🔴 #IHI Work programme for 2025 is out! 👉 https://lnkd.in/eJ9M889x Innovative Health Initiative (IHI)

Innovative Health Initiative (IHI) calls 9 and 10 with aproved texts are ⬇️

📢 New Hera Info Day incoming! 🏥 🤝 The HERA Info Days series aim to raise awareness of the @Health Emergency and Preparedness Response Authority (HERA; EU in Emergencies) and are an opportunity not only to learn more about available funding and possible collaborations, but also to network with other stakeholders, share ideas, and forge new partnerships. 🗣️ 🩺 During the morning, HERA General Director Laurent Muschel will explain HERA's role in the global health security landscape, and present its main success stories. The event will also see the participation of the Director of the European Health and Digital Executive Agency (HaDEA) Marina Zanchi, who will present the main funding opportunities in the sector. For further information, the Agenda is available here: https://lnkd.in/dAtkT-wR To register follow this link: https://lnkd.in/dwAcR8Dc

📢 LIVE NOW! Our Coordinator Caterina Buonocore is participating in the Final Event of the Revert Project! 🚀 👨🔬 The event marks a unique opportunity to learn about its impactful advancements in personalized therapies for colorectal cancer, bringing together EU policymakers, healthcare providers, patient associations, and industry experts to explore the REVERT project’s achievements and future directions. ⚙️ 🤝 In the afternoon sessions will focus on exploitation and partnership opportunities. These will cover pathways for integrating REVERT’s findings into real-world healthcare settings, with an emphasis on AI-driven solutions in genomic data processing and partnerships with industry to maximize the clinical impact. Follow the live event here: https://lnkd.in/dUACNwM2 Check the agenda here: https://lnkd.in/dMCuU2qe

📢 After a succesful Brokerage Event in November IHI keeps providing information opportunities for its 9th and 10th Call! 📚 The Info days will be held from 7 to 16 January, including dedicated sessions on the different rules and procedures of the two Calls, and on the three topics of 10th Call. Register here: https://lnkd.in/dERaVx8m

📢 📚 Eager to receive free training on clinical trials? 📝 The ERA4Health European Partnership, in partnership with ECRIN (European Clinical Research Infrastructure Network) and CZECRIN, has published a list of free training opportunities relevant for investigators/researchers interested in setting up investigator-initiated clinical studies in Europe. 🏥 🩺 Dive in for an extensive list of training opportunities on the categories of #Proposalwriting, #GCP, #ClinicalTrialMethodology, #ClinicalTrialManagement, #CTRegulations, #Ethics and #PatientsEngagement Check here the full training opportunities list: https://lnkd.in/eyNeYgmK

Research and innovation (R&I) are key in delivering evidence and tools to understand, prevent and reduce the health impacts. ⬇️

🔔🔔🔔New publication: #OneHealth Governance in the European Union Publication metadata One Health means recognition that human health, animal health and the health of our environment are inherently connected. They form a common system that demands to be treated as a whole. All too often, policy areas like agriculture, biodiversity and crisis management are treated in isolation, rather than in recognition of their place as part of a larger, interconnected ecosystem. This scientific opinion by the Group of Chief Scientific Advisors (GCSA) provides recommendations to support the successful implementation of EU policies deriving from a One Health approach. It focusses on the forms of management and governance that are best suited for encouraging collaboration across the different sectors that make up One Health whilst minimising any unintended consequences that might result from such new in approach. This opinion is published in the context of the Scientific Advice Mechanism (SAM) which provides independent scientific evidence and policy recommendations to the European institutions by request of the College of Commissioners. https://lnkd.in/gS6PxhEN